Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that new preclinical data ...

Backed by more than a dozen investors, the biotech startup will use the funding to further a Phase 1 trial of its lead program CBX-250.

Crossbow Therapeutics, Inc., a biotechnology company developing a novel class of potent and precise antibody therapies to treat ...

Ten years ago, Shirley Powers was having some pain in her neck migrating down one arm. An X-ray found enlarged lymph nodes. Those lymph nodes were cancerous, containing chronic lymphocytic leukemia, ...

A WVU Cancer Institute team led by Ashkan Emadi, M.D., Ph.D., (pictured) is the first in the world to examine the efficacy of subcutaneous blinatumomab in treating one of the rarest and most ...

A TRUE FULL CIRCLE MOMENT FOR HER FAMILY. DAISY MEYER RECENTLY CELEBRATED HER 16TH BIRTHDAY. LOVE SCHOOL IS IN BAND AND IS A FREQUENT PATIENT AT PENN STATE HEALTH GOLISANO CHILDREN’S HOSPITAL. DAISY ...